WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016093474) COMPOSITION FOR PREVENTING, IMPROVING OR TREATING PSORIASIS COMPRISING IMMUNOMODULATOR AND GLUCOSAMINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/093474    International Application No.:    PCT/KR2015/010162
Publication Date: 16.06.2016 International Filing Date: 25.09.2015
IPC:
A61K 38/13 (2006.01), A61K 31/7008 (2006.01), A61P 17/00 (2006.01)
Applicants: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION [KR/KR]; 30, Pildong-ro 1-gil Jung-gu Seoul 04620 (KR)
Inventors: LEE, Ai-Young; (KR)
Agent: LEE, Myoung-Jin; (KR)
Priority Data:
10-2014-0175935 09.12.2014 KR
Title (EN) COMPOSITION FOR PREVENTING, IMPROVING OR TREATING PSORIASIS COMPRISING IMMUNOMODULATOR AND GLUCOSAMINE
(FR) COMPOSITION POUR LA PRÉVENTION, L'AMÉLIORATION OU LE TRAITEMENT DU PSORIASIS, COMPRENANT UN IMMUNOMODULATEUR ET DE LA GLUCOSAMINE
(KO) 면역 조절제 및 글루코사민을 포함하는 건선 예방, 개선 또는 치료용 조성물
Abstract: front page image
(EN)The present invention relates to a composition for preventing, improving or treating psoriasis comprising an immunomodulator and glucosamine. Coadministration of cyclosporine and glucosamine according to the present invention can exhibit an extremely greater effect of treatment and improvement of psoriasis compared to single administration of cyclosporine and glucosamine, while also reducing the dose of cyclosporine, long term administration of which is difficult due to side effects, and upon discontinuance of which lesions are prone to worsen to the original state thereof.
(FR)La présente invention concerne une composition pour la prévention, l'amélioration ou le traitement du psoriasis comprenant un immunomodulateur et de la glucosamine. L'administration conjointe de cyclosporine et de glucosamine selon la présente invention peut entraîner un effet nettement plus important en termes de traitement et d'amélioration du psoriasis par rapport à l'administration seule de cyclosporine et de glucosamine, tout en réduisant la dose de cyclosporine, dont l'administration à long terme est difficile en raison des effets secondaires, et dont la cessation peut entraîner un retour des lésions à leur état d'origine.
(KO)본 발명은 면역 조절제 및 글루코사민을 포함하는 건선 예방, 개선 또는 치료용 조성물에 관한 것이다. 본 발명에 따른 사이클로스포린과 글루코사민의 병용 투여는, 부작용으로 인하여 장기 투여가 어렵고, 중단 시 원상으로 병변이 악화되기 쉬운 사이클로스포린의 용량을 감량하면서도, 사이클로스포린과 글루코사민의 단독 투여보다 매우 높은 건선 치료 또는 개선 효과를 나타낼 수 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)